Michael B. Atkins, Alan Arrieira Azambuja, Caroline Robert, Reinhard Dummer, Céleste Lebbé, Paul D. Nathan, Andreia Cristina de Melo, Igor A. Utyashev, Bart Neyns, Ivan Marquez-Rodas, Justin C. Moser, Heather May Shaw, Anna Maria Di Giacomo, Wei Wu, Joseph Elan Grossman, Steven O'Day, Patrick Alexander Ott, Dirk Schadendorf, Eva Muñoz Couselo, Paolo Antonio Ascierto. "Botensilimab (BOT) ± balstilimab (BAL) in patients (pts) with advanced cutaneous melanoma (cMEL) refractory/resistant (R/R) to anti–PD-(L)1 ± CTLA-4: A phase 2 trial.." Journal of Clinical Oncology (2026). https://doi.org/10.1200/jco.2026.44.16_suppl.9543